KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$24.43
+0.33%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$24.35
From 52W high−13.83%
Volume1.24M
Market cap$1.46B
P/E (TTM)—
P/S (TTM)13.6x
Div yield—
Key dataSep 18, 2026
Open
$24.35
From 52W high
−13.83%
Volume
1.24M
Market cap
$1.46B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−9.3x
P/E (TTM)
—
RSI (14)
47.7
MomentumView details →
1D Return
+0.33%
YTD Return
−6.82%
SummaryUpdated Jul 1, 2026
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) is a wearable medical device and digital healthcare company founded in 2014 and headquartered in Kirkland, Washington. The company went public in March 2025 and focuses on transforming patient outcomes in cardiovascular disease through innovative monitoring and therapeutic intervention technologies. Kestra specializes in developing connected medical devices that are designed to be intuitive and intelligent, with their primary focus on protecting patients at elevated risk of sudden cardiac arrest.
Similar companies
Latest newsMore news →
Kestra Medical Technologies, Ltd. reported financial results for the first quarter of fiscal year 2027, ended July 31, 2026.6d agoJeffrey Lawrence Schwartz, a Director and 10% Owner of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), sold 3,890 common shares for about $97,942 on September 8, 2026 to cover tax withholding obligations tied to restricted stock unit vesting.9d agoKestra Medical Technologies announced it will report its first quarter fiscal 2027 financial results after market close on September 14, 2026.20d ago